Skip to content

20-072 - Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure

Status: open

Double Blind Randomized Phase II Placebo Controlled Trial Using rhDNase to Reduce Mortality in COVID-19 Patients with Respiratory Failure

Treatment for Respiratory Failure

Contact Us Or call (251) 445-9834

Description

To assess the safety and efficacy of Pulmozyme® in patients with respiratory failure from COVID-19 positive patients who are in respiratory failure.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

This link will open in a new tab or window.